Mesoblast (MESO) EBT Margin Growth (3y) (2017 - 2023)
Mesoblast (MESO) EBT Margin Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -104,882.00 |
| Mar 31, 2023 | -13,424.00 |
| Dec 31, 2022 | 21,304.00 |
| Sep 30, 2022 | -36,721.00 |
| Jun 30, 2022 | 24,816.00 |
| Mar 31, 2022 | 154,645.00 |
| Dec 31, 2021 | 152,111.00 |
| Sep 30, 2021 | 90,804.00 |
| Jun 30, 2021 | 60,940.00 |
| Mar 31, 2021 | 111,941.00 |
| Dec 31, 2020 | -97,978.00 |
| Sep 30, 2020 | -109,173.00 |
| Jun 30, 2020 | 538,766.00 |
| Mar 31, 2020 | 60,180.00 |
| Dec 31, 2019 | 398,887.00 |
| Sep 30, 2019 | 594,817.00 |
| Jun 30, 2019 | -108,792.00 |
| Mar 31, 2019 | -205,932.00 |
| Dec 31, 2018 | -166,193.00 |
| Sep 30, 2018 | -149,473.00 |